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Abstract 
 
Background 
The transradial access (TRA) site has become the default access site for PCI in the UK with 
randomized trials and national registry data showing reductions in mortality associated with 
TRA utilization.  This study evaluates regional changes in access site practice in England and 
Wales over time and whether changes in access site practice has been uniform nationally and 
across different patient sub-groups, and provide national estimates for the potential number of 
lives ‘saved’ or ‘lost’ associated with regional differences in access site practice. 
Methods and Results 
Using the BCIS (British Cardiovascular Intervention Society) database, we investigated 
outcomes for growth of TRA in different regions in England and Wales in 448,853 patients 
who underwent PCI, 2005-2012. Multiple logistic regressions used to quantify the effect of 
TRA on 30-day mortality and quantify lives ‘saved’ and ‘lost’ by differences in TRA 
adoption.  TRA utilization increased from 14.0% to 58.6% in 417,038 PCI patients with large 
variations in different parts of the country. TRA was independently associated with a 
decreased risk of 30-day mortality (OR=0·70; 95%CI=0·66-0·74) with significant but small 
differences observed across different regions. The number of estimated lives ‘saved’ was 450 
(95%CI=275-650) and estimate that an additional 264 (95%CI=153-399) lives would have 
been saved if TRA adoption were uniform nationally. 
Conclusions 
TRA has become the dominant PCI approach in the UK with a wide variation in different 
parts of the country. Changes in practice have contributed to mortality reductions, whilst 
inequalities have resulted in missed opportunities for further improvements.  
 
Key words: mortality, angioplasty, catheterization 
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Introduction 
 
 Since the introduction of the trans-radial (TRA) approach for diagnostic coronary 
angiography1 and then percutaneous coronary intervention (PCI)2 the radial artery has 
increasingly been adopted as the primary access site for cardiac catheterization in Europe and 
Asia, with growing uptake in the US.3 Adoption of the TRA access site is associated with a 
reduced rate of access site related bleeding complications4 and mortality5-10 as well as earlier 
ambulation,11 improved patient comfort and greater patient satisfaction12 Bleeding 
complications are amongst the commonest complications encountered in contemporary PCI 
and are independently associated with a 3-fold increase in mortality13, 14 It is widely believed 
that the consistently observed lower mortality risk that is associated with the choice of TRA 
is mediated through a reduction in major bleeding complications,8, 15 although there may be 
additional mechanisms that contribute to this mortality reduction independent to decreases in 
major bleeding.16 We have previously reported that the magnitude of this mortality reduction 
associated with TRA use is related to baseline bleeding risk7 
 Recent data from the UK has suggested that TRA utilization has grown from 16% to 
become the predominant access site in PCI for both elective and ACS indications6, 17 
Similarly, an increase in the radial approach has been reported in the US, albeit at a slower 
rate, from 1.2% in 2007 to 16% by 201218, 19 However, whilst previous national analyses 
have reported an association between radial access site choice and a reduced risk of mortality 
in high risk cohorts undergoing PCI5, 6, 9, 20 estimates regarding the number of potential deaths 
that may have been avoided through a change in access site practice from a national 
perspective have not previously been reported. Additionally there have been no national 
estimates about potential lives ‘lost’ as a consequence of regional differences and/or 
inequalities in the rates of increased radial access use for PCI. 
 We studied changes in PCI access site practice from a national perspective in England 
and Wales over an eight-year period using the British Cardiovascular Interventional Society 
database. Specifically, we assessed (i) changes in the characteristics of patients undergoing 
PCI over this timeframe, (ii) growth of TRA amongst different patient subgroups and (iii) 
differences in access site utilization across different regions. Finally, we estimated the 
number of potential deaths that may have been avoided by a wholesale change to TRA in 
access site practice across different parts of the country. 
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Methods 
 
The British Cardiovascular Intervention Society Database 
 
 The British Cardiovascular Intervention Society (BCIS) collects data on all PCI 
procedures in the UK21, 22. The data collection is coordinated by the National Institute of 
Cardiovascular Outcomes Research (http://www.ucl.ac.uk/nicor/) via the Central Cardiac 
Audit Database. In 2011, this dataset collected information on 99.4% of all PCI procedures 
performed in NHS Hospitals in England and Wales. 
 The BCIS-NICOR database contains a total of 113 variables, which includes 
information on clinical variables, procedural parameters and patient outcomes. Mortality 
tracking is undertaken by the Medical Research Information Service (MRIS) using patients’ 
NHS number that provides a unique identifier for any person registered with the NHS in 
England and Wales. 
Study inclusions 
 The data presented relate to all reported PCI procedures undertaken in patients in the 
United Kingdom between January 1, 2005, and December 31, 2012 (N=448853). PCI 
procedures performed via the left or right femoral artery or the left or right radial artery were 
included in the TFA and TRA cohorts, respectively (N=423032). Patients in whom the access 
site was unclear, missing or where multiple access sites were attempted / used and the 
primary access site that was used for the procedure could not be identified were excluded 
(N=25821; 5.8%). 
 
Statistical analyses 
All analyses were conducted in Stata v13.1 with an alpha level of 5% used throughout. 
We obtained spatial maps of England and Wales at Strategic Health Authority (SHA) level, a 
high level National Health Service (NHS) structure geography using the spmap command. 
Next, we proceeded with quantifying the effect of arterial access type (femoral only 
vs. radial only) on 30-day mortality, controlling for various patient characteristics: age, 
gender, diabetes, hypercholesterolemia, hypertension, peripheral vascular disease, 
cerebrovascular event, renal history, previous MI, previous PCI, previous CABG, family 
history of CAD, smoking (never smoked, ex-smoker and current smoker), indication for 
intervention (Elective, NSTEMI and STEMI), cardiogenic shock pre-procedure and 
ventilation pre-procedure. Area location deprivation (based on the 2007 Index of Multiple 
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Deprivation, or IMD) was not included in the model since it was completely missing for 
Wales. For 42.4% of the 423032 patients with femoral- or radial-only access type, values 
were missing for at least one covariate (Figure 1). Therefore, we employed chained equations 
multiple imputation methods (mi impute chained command) to impute missing values 
through linear, logistic or multinomial logistic regressions. We generated 50 datasets with 
imputed values, and through these we were able to include 98.6% of the patients (femoral 
only and radial only) in the logistic regression analysis. This analysis followed a mixed-
effects model specification (xtlogit command) to account for the nested structure of the data 
(patients nested within geographies) through the inclusion of random effects for Primary Care 
Trusts (or PCTs; a medium-level NHS structure geography, abolished in 2013), and was 
controlled for all the covariates previously mentioned as well as SHA (as a fixed-effect). The 
regression model also included interaction terms between access type and SHA, allowing us 
to estimate a different effect for access type in each geographical areas, after controlling for 
other covariates. The specified model was then run with the mi estimate command, in order to 
combine estimates across the 50 imputed datasets. 
Using the combined model estimates (across the 50 datasets) with the mimrgns 
command (and necessarily assuming that the random-effect of the model was zero), we 
calculated the probability of 30-day mortality by arterial access type, within each SHA and 
year while setting all covariates at their mean values within each SHA-year stratum. This 
allowed us to calculate the difference of these probability estimates within each strata and 
pool their errors to obtain the standard error of the difference. These differences in the 
patient-level effect of access type were then aggregated for each SHA-year stratum using the 
number of performed operations, allowing us to calculate the number of lives ‘saved’ and 
‘lost’ at 30 days (and their 95% confidence intervals). We defined as ‘saved’ lives the number 
of 30 day deaths that were prevented with the use of radial-only access, compared to a 
hypothetical scenario where only femoral-only operations were performed within the stratum. 
Lives ‘lost’ (speculative) were similarly defined as the number of 30-day deaths that would 
have been prevented with the use of radial-only access, in hypothetical scenarios where their 
rate was higher than what was observed in practice. In the first scenario, the rate was set to 
the highest observed radial-only rate across all strata and years (82.9%), which was assumed 
to have been feasible for the whole of our study period. However, this overall maximum rate 
might have not been possible in earlier years because of inexperience, equipment 
inefficiencies or other factors. Therefore, we used a second scenario to calculate lives ‘lost’ 
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(conservative), where the hypothetical radial-only access rate varied over time, and it was 
assumed to be the highest observed stratum rate within the respective year. 
Using a similar modeling approach, multiple imputation multiple logistic regression 
with the logit and mimrgns commands, we also investigated the relationship between patient 
characteristics, year and region with choice of arterial access type. The same database of 50 
imputed datasets was used for this purpose, but this time we encountered non-convergence 
issues with mixed-effects models (xtlogit) and we had to compromise with a simpler fixed-
effects only model. All covariates previously listed for the mortality analysis were included 
as potential predictors, with the exception of arterial access type which was now the outcome. 
The mimrgns command was use to obtain the probability of radial-only access by year, 
setting all covariates to their mean levels within each year. 
Finally, we also ran a propensity score matching sensitivity analysis for mortality, 
with the teffects psmatch command. Under this analysis we calculated the average treatment 
effect of radial- vs femoral-only access after propensity score adjustment, as a probability 
difference over the 50 imputed datasets. The propensity score for each patient was calculated 
using a logistic model, in which we included all the covariates that were included in the main 
analyses. 
Results 
 
 A total of 448,853 patients underwent PCI from 2005 to 2012 in England and Wales, 
of whom 25,821 (5·8%) were excluded because access site utilized was either missing, 
unclear or multiple access sites were attempted and primary access site utilized could not be 
identified. Figure 1 illustrates the flowchart of patient inclusion and exclusion. A total of 
159,425 PCI procedures (35·5%) were undertaken through the TRA. TRA utilization 
increased from 14% to 58·6% between 2005 and 2012. Table 1 illustrates changes in the 
clinical and procedural demographics in patients undergoing PCI from 2005-2012. The 
number of patients per year undergoing PCI increased from 37,658 in 2005 to 65,476 in 
2012. Over time, mean patient age as well as diabetes and renal disease prevalence increased, 
and patients were more likely to undergo PCI for STEMI indications but less likely to 
undergo elective PCI. 
 Figures 2a and 2b illustrates rates of TRA utilization in Primary Care Trusts in 
England and Local Health Boards in Wales, between 2005-2012. It can be seen graphically 
that TRA utilization has increased in all regions of England and Wales over time, but that 
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there were very large variations in TRA adoption in different parts of the country, with the 
greatest growth in the North East, North West, Midlands and Wales whilst adoption in the 
South East Coast and London has been the slowest.  
 Table 2 presents the clinical and procedural demographics of patients undergoing 
TRA PCI between 2005-2012. Over this time period PCI undertaken through TRA were in 
increasingly more complex patients, who were older, more likely to have ACS, and 
cardiogenic shock. Table 2 also reports some of the inequalities of TRA adoption observed 
nationally. Uptake of TRA was slowest in the least deprived areas and greatest in those areas 
at highest deprivation and there was significant variation in TRA uptake amongst different 
SHAs, with rates between 4·9% (Yorkshire and the Humber) and 37·6% (North East) in 2005 
and between 28·0 % (South East Coast) and 81·2 % (North East) in 2012. 
 Table 3 illustrates independent predictors for TRA adoption in England and Wales. 
The odds of patients undergoing PCI in 2012 were over 11 times higher compared to 2005 
(OR=11·6; 95%CI=11·2-12·0) compared to 2005. The odds of patients undergoing PCI 
through the radial artery were lower if they were female, elderly, had previous CABG or 
presented with cardiogenic shock. SHA appeared to be an important independent predictor of 
access site choice, and patients in the South East Coast were much less likely to undergo PCI 
through the TRA route, than patients in the North East (OR=0·07; 95%CI=0·07-0·08). Table 
4 illustrates predictors of 30-day mortality, with TRA utilization independently associated 
with a decreased risk of 30-day mortality (OR=0·70; 95%CI=0·66-0·74). There were no 
significant differences observed in the mortality benefit observed with TRA adoption in the 
different SHA studied once differences in baseline covariates were adjusted for. An 
alternative model without interaction terms, where the other covariates can be interpreted, is 
provided for completeness in Supplementary Table 1. 
 Estimated lives ‘saved’ and ‘lost’ (conservative), as a consequence of change in 
access site practice over time in each individual SHA, are presented in Supplementary Tables 
2 and 3 and graphically in Figure 3. Over the eight-year study period, the fewest lives ‘saved’ 
occurred in the South East Coast with 0 (95%CI=0-9) and the greatest number in the South 
West with 79 lives (95%CI=56-102), while the total number of estimated lives ‘saved’ was 
450 (95%CI=275-650). In terms of conservative lives ‘lost’, if TRA adoption was uniform 
nationally to the highest observed SHA rates within each year (which was consistently in the 
North-East), an additional 264 (95%CI=153-399) lives would have been saved between 
2005-2012. Speculative lives ‘lost’ when compared to a hypothetical scenario where radial 
access percentages across all strata are 82.9%, the highest percentage observed are presented 
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in Supplementary Table 4 and Supplementary Figure 1, and the overall estimate was 385 
(95%CI=224-573), over the study period. 
 Results from the propensity score matching sensitivity analysis on 30-day mortality 
agreed with the main analysis results. The average treatment effect of radial-only vs femoral-
only was estimated to be -0·0052 (95% CI: -0·0067 to -0·0036), compared to -0·0046 (95% 
CI: -0·0058 to -0·0034) from the main analysis. The comparative benefit of TRA appeared at 
least as strong in the sensitivity analyses. 
Discussion 
 
 TRA has grown globally to become the predominant access site for PCI procedures 
although significant differences in its adoption have been reported worldwide. Our analysis 
has shown that the radial artery has become the predominant access site for PCI procedures in 
England and Wales over a period of eight years, with a rate of around 60% nationally in 
2012. Adoption of TRA has been widely heterogeneous in different parts of the country, 
varying between 28·0% in the South coast and 81·2% in the North-East, in 2012. We report 
that this change in national access site practice is associated with utilization of TRA in 
increasingly more complex patients, such as those with ACS, the elderly and those with 
cardiogenic shock. We estimated that this change in access site practice nationally has 
contributed to 450 lives ‘saved’ whilst inequalities in these changes have contributed to over 
260 lives ‘lost’, over a period of eight years.   
 In the current study we have evaluated temporal trends in TRA adoption nationally in 
England and Wales and show significant heterogeneity in TRA adoption across the country 
with TRA utilization varying from 28% in the South coast to 81.2% in the North East of 
England. Our analysis shows that even when differences in baseline clinical demographics 
that may influence TRA choice are accounted for, significant heterogeneity in TRA adoption 
exists across SHA with patients in the South East Coast 93% (OR 0.07 95% CI 0.073-0.080; 
P<0.001) less likely to undergo PCI through the TRA approach than those patients in the 
North East. Other studies derived from the NCDR have suggested significant heterogeneity 
across the US with rates of TRA adoption varying from 12 to 38% in the Northeast and South 
respectively19  
 The growing number of dedicated training courses and workshops have helped to 
expand interest in this technique worldwide23 with many of the TRA training courses in the 
UK based in the areas with the greatest adoption of the TRA such as the West Midlands. This 
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highlights the importance of such dedicated training courses and workshops and has 
important implications for other countries such as the United States who are still in the early 
stages of radial adoption nationally. Indeed, in a recent survey around barriers to TRA 
adoption in Veterans’ Administration catheterization laboratories undertaken in the United 
States, important barriers such as lack of training opportunities (18%), perceived long radial 
learning curve for cases (43%) and lack of support from other interventional cardiologists or 
other catheterization staff (20%) were identified as important barriers that prevented adoption 
in many VA laboratories24 It is possible that many of these findings are equally applicable to 
UK interventional practice. Newly appointed consultants are more likely to have received 
formal training in use of the TRA in PCI than established consultants who often lack such 
training opportunities, and are limited by operational barriers within their departments. In a 
recent survey amongst 204 interventional cardiologists across the UK, there was a correlation 
between access site preference for PCI and years since qualification, with operators whose 
primary access site choice was femoral having been qualified on average 5 years earlier than 
those in whom radial was their default choice25 It is unclear from our current analysis 
whether SHAs in which the greatest adoption of TRA are also the ones in which most new 
interventional appointments have been undertaken. Finally, the SHA in which the greatest 
growth of TRA has been observed are also the SHA were the earliest adopters and pioneers 
of TRA practice are based, many of whom undertook periods of training in the Netherlands 
where use of TRA for PCI was pioneered. It is possible that the high rates of TRA adoption 
in these regions have been driven by these early pioneers through education and active 
promotion and support of TRA use in their units. 
 A recent meta-analysis of 42 studies in over ½ a million patients has reported that 
peri-procedural major bleeding complications in the PCI setting are independently associated 
with a 3-fold increase in mortality13 with recent NCDR registry data suggesting that 1 in 7 of 
all PCI deaths in the US were related to bleeding complications26 Access site related bleeding 
complications account for up to half of bleeding events recorded during PCI14, 27 with 
adoption of the TRA associated with reductions in major bleeding complications and 
mortality in selected UK and North American cohorts6, 9, 17 The recent MATRIX trial 
suggests that there is no significant interaction between pharmacology and anti-platelet usage 
and the mortality benefit associated with TRA10 Recent work data derived from national 
registries and randomized controlled trials has suggested that TRA use in primary PCI is 
associated with a similar decreased mortality risk as observed in the switch from 
thrombolysis to primary PCI for revascularization5, 9, 28 Previous studies have suggested that 
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patients at highest risk of bleeding complications gain the greatest benefit from adoption of 
the TRA approach, but are least likely to receive it7 Indeed our recent work suggests a 
mortality benefit associated with TRA use across both elective as well as ACS indications for 
PCI, although the mortality benefit associated with TRA use in elective cases was modest.6 
Whilst reductions in major bleeding may contribute to the mortality reductions associated 
with TRA, other studies have suggested that the reduction in mortality associated with TRA 
adoption can not be explained by the reduction in major bleeding alone.16  
 Our analysis has estimated that over the period of eight years studied, this national 
change in access site practice has contributed to around 450 ‘saved’ lives with the greatest 
number of lives ‘saved’ in the South West (79 lives), West Midlands (68 Lives) and North 
East (65 lives). We have also shown that once differences in baseline covariates were 
adjusted for, the magnitude of benefit of TRA was similar across different SHAs studied, and 
that on average TRA is associated with a 32% reduction in the risk of mortality (OR=0·70; 
95% CI=0·66-0·74) which is similar in magnitude to recent RCTs (albeit reporting outcomes 
in the ACS setting) including MATRIX (RR 0·72, 95% CI 0·53-0·99; p=0·045) 10, RIFLE-
STEACS (43% reduction in CV mortality) 28, STEMI-RADIAL (26% reduction)29 and 
RIVAL (STEMI group 0·60 OR 0·38–0·94, P=0.026) 30. The significant heterogeneity in 
TRA adoption across the UK, even after adjusting for differences in clinical and procedural 
characteristics, has resulted in lost opportunities in optimizing PCI safety, where we have 
conservatively estimated that as many as 264 additional lives may have been ‘lost’ due to 
inequalities in TRA adoption. 
 Our analysis has suggested that even after adjustment for clinical presentation, year of 
procedure and strategic health authority, patients at higher risk of bleeding complications 
such as the elderly and females and patients presenting with hemodynamic instability are less 
likely to receive TRA. This is in agreement to observations recorded from North American 
datasets,15, 31 despite the greatest potential benefit in limiting bleeding complications in these 
patients, supported by recent data derived from a radial default centre in the UK32 Significant 
challenges remain in ensuring more widespread adoption of TRA in PCI particularly in those 
patients at highest risk of bleeding complications who derive greatest benefit. Finally, there 
will be a proportion of patients, by means of their clinical presentation with significant 
haemodynamic compromise or through anatomic reasons such as brachiocephalic disease, 
radial loops or hemodialysis access where a TRA procedure cannot be completed. In such 
patients, optimal femoral access site practice, such as micropuncture techniques using 
fluoroscopic or ultrasound guidance for femoral access should be considered. 
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 Our analysis has a number of limitations. First and foremost, this is an observational 
study and the risk of confounding is real. TFA use is often the preferred access site choice for 
patients who are hemodynamically unstable and more complex (and consequently at higher 
risk of mortality)20 To minimize the confounding risk, we used advanced multiple regression 
models in which we controlled for important covariates and adverse procedural and clinical 
characteristics; propensity score matching sensitivity analyses verified the findings from the 
main analyses. However, we may still be over-estimating the effectiveness of TRA. Second, 
missing data is a common problem for observational databases and the BCIS database is no 
exception. We used multiple imputation approaches, which offer excellent protection against 
missing completely at random (MCAR) and missing at random (MCAR) mechanisms for the 
data33, 34 and managed to include 96·7% of eligible patients in the analyses. However, 
information for some covariates might be missing not at random (MNAR) and thus 
introducing bias into our estimates, although multiple imputation can still offer some 
protection in this case. Third, we could not control the regression models for patient residence 
area deprivation, since the information was completely missing for Wales. Nevertheless we 
expect the additional predictive power of deprivation to have been small, considering the 
large number of patient characteristics that were included in the models. Fourth, the BCIS 
dataset does not contain information on crossover between access sites due to failure for 
cases in which multiple access sites were used, although such cases were excluded from the 
analysis when the access site utilised was not clear. Most multiple access site cases are likely 
to represent cases in which radial was attempted and then the case was converted to femoral, 
however, up to 10-30% can be procedures that were initially started through a femoral 
approach and switched to radial10, 28, 29. In addition, these cases are likely to be more 
complicated and if classed as femoral, since they are the majority, the analyses would tend to 
overestimate the relative benefit of radial. Nevertheless, in a sensitivity analysis where we 
classed all multiple access procedures where femoral was attempted as femoral, the effect 
was almost identical with OR=0·69 (95%CI=0·65-0·73). Finally, as with all such 
observational analyses, the association of TRA choice in PCI and decreased mortality cannot 
infer causality, although the mortality reductions that we report are in line to those reported in 
contemporary RCTs. 
 In conclusion, our analyses have shown that TRA has grown to be the dominant 
access site for PCI procedures in England and Wales over a period of eight years although the 
adoption of TRA has not been uniform, with a wide variation in different parts of the country. 
Although patients who have the highest risk of bleeding complications (elderly, women) are 
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least likely to have PCI undertaken through TRA, there has been a change in national access 
site with TRA utilization in increasingly more complex patients, such as those with ACS, the 
elderly and those with cardiogenic shock or those requiring circulatory or inotropic support. 
TRA was independently associated to mortality reductions and over eight years, we estimated 
that this change in national access site practice has contributed to over 450 lives saved, whilst 
inequalities in changes in access site practice have contributed to over 260 lives ‘lost’. 
Significant challenges remain in a more uniform adoption of TRA nationally even in the UK 
where TRA represent the commonly used access site, particularly in those patients at highest 
risk of bleeding complications who have most to benefit. More uniform access to training 
opportunities nationally may be needed, to maximize the clinical benefit for patients 
undergoing PCI. 
 
 
Acknowledgments 
We would like to thank the British Cardiovascular Intervention Society and the Office of 
National Statistics for the wealth of information they have collected and systematically 
organized, which made this study possible. 
 
Funding sources: None 
 
Disclosures: All authors have completed the Unified Competing Interest form at 
www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and 
declare: MRC Health eResearch Centre Grant MR/K006665/1 supported the time and 
facilities of two investigators (EK and IB). 
References 
 
1. Campeau L. Percutaneous radial artery approach for coronary angiography. 
Catheterization and cardiovascular diagnosis. 1989;16:3-7. 
2. Kiemeneij F and Laarman GJ. Percutaneous transradial artery approach for coronary 
stent implantation. Catheterization and cardiovascular diagnosis. 1993;30:173-8. 
3. Bertrand OF, Rao SV, Pancholy S, Jolly SS, Rodes-Cabau J, Larose E, Costerousse 
O, Hamon M and Mann T. Transradial approach for coronary angiography and interventions: 
results of the first international transradial practice survey. JACC Cardiovascular 
interventions. 2010;3:1022-31. 
4. Bertrand OF, Belisle P, Joyal D, Costerousse O, Rao SV, Jolly SS, Meerkin D and 
Joseph L. Comparison of transradial and femoral approaches for percutaneous coronary 
13 
 
interventions: a systematic review and hierarchical Bayesian meta-analysis. American heart 
journal. 2012;163:632-48. 
5. Khan MA, Ahmed F, Neyses L and Mamas MA. Atrial fibrillation in heart failure: 
The sword of Damocles revisited. World J Cardiol. 2013;5:215-27. 
6. Ratib K, Mamas MA, Anderson SG, Bhatia G, Routledge H, De Belder M, Ludman 
PF, Fraser D, Nolan J, British Cardiovascular Intervention S and the National Institute for 
Cardiovascular Outcomes R. Access site practice and procedural outcomes in relation to 
clinical presentation in 439,947 patients undergoing percutaneous coronary intervention in 
the United kingdom. JACC Cardiovascular interventions. 2015;8:20-9. 
7. Mamas MA, Anderson SG, Carr M, Ratib K, Buchan I, Sirker A, Fraser DG, Hildick-
Smith D, de Belder M, Ludman PF, Nolan J, British Cardiovascular Intervention S and the 
National Institute for Cardiovascular Outcomes R. Baseline bleeding risk and arterial access 
site practice in relation to procedural outcomes after percutaneous coronary intervention. 
Journal of the American College of Cardiology. 2014;64:1554-64. 
8. Chase AJ, Fretz EB, Warburton WP, Klinke WP, Carere RG, Pi D, Berry B and 
Hilton JD. Association of the arterial access site at angioplasty with transfusion and 
mortality: the M.O.R.T.A.L study (Mortality benefit Of Reduced Transfusion after 
percutaneous coronary intervention via the Arm or Leg). Heart. 2008;94:1019-25. 
9. Baklanov DV, Kaltenbach LA, Marso SP, Subherwal SS, Feldman DN, Garratt KN, 
Curtis JP, Messenger JC and Rao SV. The prevalence and outcomes of transradial 
percutaneous coronary intervention for ST-segment elevation myocardial infarction: analysis 
from the National Cardiovascular Data Registry (2007 to 2011). Journal of the American 
College of Cardiology. 2013;61:420-6. 
10. Valgimigli M, Gagnor A, Calabro P, Frigoli E, Leonardi S, Zaro T, Rubartelli P, 
Briguori C, Ando G, Repetto A, Limbruno U, Cortese B, Sganzerla P, Lupi A, Galli M, 
Colangelo S, Ierna S, Ausiello A, Presbitero P, Sardella G, Varbella F, Esposito G, Santarelli 
A, Tresoldi S, Nazzaro M, Zingarelli A, de Cesare N, Rigattieri S, Tosi P, Palmieri C, 
Brugaletta S, Rao SV, Heg D, Rothenbuhler M, Vranckx P, Juni P and Investigators M. 
Radial versus femoral access in patients with acute coronary syndromes undergoing invasive 
management: a randomised multicentre trial. Lancet. 2015. 
11. Brasselet C, Tassan S, Nazeyrollas P, Hamon M and Metz D. Randomised 
comparison of femoral versus radial approach for percutaneous coronary intervention using 
abciximab in acute myocardial infarction: results of the FARMI trial. Heart. 2007;93:1556-
61. 
12. Nathan S and Rao SV. Radial versus femoral access for percutaneous coronary 
intervention: implications for vascular complications and bleeding. Current cardiology 
reports. 2012;14:502-9. 
13. Kwok CS, Rao SV, Myint PK, Keavney B, Nolan J, Ludman PF, de Belder MA, Loke 
YK and Mamas MA. Major bleeding after percutaneous coronary intervention and risk of 
subsequent mortality: a systematic review and meta-analysis. Open heart. 2014;1:e000021. 
14. Kwok CS, Khan MA, Rao SV, Kinnaird T, Sperrin M, Buchan I, de Belder MA, 
Ludman PF, Nolan J, Loke YK and Mamas MA. Access and non-access site bleeding after 
percutaneous coronary intervention and risk of subsequent mortality and major adverse 
cardiovascular events: systematic review and meta-analysis. Circulation Cardiovascular 
interventions. 2015;8. 
15. Rao SV, Ou FS, Wang TY, Roe MT, Brindis R, Rumsfeld JS and Peterson ED. 
Trends in the prevalence and outcomes of radial and femoral approaches to percutaneous 
coronary intervention: a report from the National Cardiovascular Data Registry. JACC 
Cardiovascular interventions. 2008;1:379-86. 
14 
 
16. Mehta SR, Jolly SS, Cairns J, Niemela K, Rao SV, Cheema AN, Steg PG, Cantor WJ, 
Dzavik V, Budaj A, Rokoss M, Valentin V, Gao P, Yusuf S and Investigators R. Effects of 
radial versus femoral artery access in patients with acute coronary syndromes with or without 
ST-segment elevation. Journal of the American College of Cardiology. 2012;60:2490-9. 
17. Anderson SG, Ratib K, Myint PK, Keavney B, Kwok CS, Zaman A, Ludman PF, de 
Belder MA, Nolan J, Mamas MA, on behalf of the British Cardiovascular Intervention S and 
the National Institute for Cardiovascular Outcomes R. Impact of age on access site-related 
outcomes in 469,983 percutaneous coronary intervention procedures: Insights from the 
British Cardiovascular Intervention Society. Catheterization and cardiovascular 
interventions : official journal of the Society for Cardiac Angiography & Interventions. 2015. 
18. Feldman DN, Swaminathan RV, Kaltenbach LA, Baklanov DV, Kim LK, Wong SC, 
Minutello RM, Messenger JC, Moussa I, Garratt KN, Piana RN, Hillegass WB, Cohen MG, 
Gilchrist IC and Rao SV. Adoption of radial access and comparison of outcomes to femoral 
access in percutaneous coronary intervention: an updated report from the national 
cardiovascular data registry (2007-2012). Circulation. 2013;127:2295-306. 
19. Bradley SM, Rao SV, Curtis JP, Parzynski CS, Messenger JC, Daugherty SL, 
Rumsfeld JS and Gurm HS. Change in hospital-level use of transradial percutaneous 
coronary intervention and periprocedural outcomes: insights from the national cardiovascular 
data registry. Circulation Cardiovascular quality and outcomes. 2014;7:550-9. 
20. Mamas MA, Anderson SG, Ratib K, Routledge H, Neyses L, Fraser DG, Buchan I, de 
Belder MA, Ludman P, Nolan J, British Cardiovascular Intervention S and National Institute 
for Cardiovascular Outcomes R. Arterial access site utilization in cardiogenic shock in the 
United Kingdom: is radial access feasible? American heart journal. 2014;167:900-8 e1. 
21. Ludman PF and British Cardiovascular Intervention S. British Cardiovascular 
Intervention Society Registry for audit and quality assessment of percutaneous coronary 
interventions in the United Kingdom. Heart. 2011;97:1293-7. 
22. Mamas MA, Anderson SG, O'Kane PD, Keavney B, Nolan J, Oldroyd KG, Perera D, 
Redwood S, Zaman A, Ludman PF, de Belder MA, British Cardiovascular Intervention S and 
the National Institute for Cardiovascular Outcomes R. Impact of left ventricular function in 
relation to procedural outcomes following percutaneous coronary intervention: insights from 
the British Cardiovascular Intervention Society. European heart journal. 2014;35:3004-12. 
23. Hamon M, Pristipino C, Di Mario C, Nolan J, Ludwig J, Tubaro M, Sabate M, Mauri-
Ferre J, Huber K, Niemela K, Haude M, Wijns W, Dudek D, Fajadet J, Kiemeneij F, 
European Association of Percutaneous Cardiovascular I, Working Group on Acute Cardiac 
Care of the European Society of C and Working Group on Thrombosis on the European 
Society of C. Consensus document on the radial approach in percutaneous cardiovascular 
interventions: position paper by the European Association of Percutaneous Cardiovascular 
Interventions and Working Groups on Acute Cardiac Care** and Thrombosis of the 
European Society of Cardiology. EuroIntervention : journal of EuroPCR in collaboration 
with the Working Group on Interventional Cardiology of the European Society of 
Cardiology. 2013;8:1242-51. 
24. Helfrich CD, Tsai TT, Rao SV, Lemon JM, Eugenio EC, Vidovich MI, Shroff AR, 
Speiser BS and Bryson CL. Perceptions of advantages and barriers to radial-access 
percutaneous coronary intervention (PCI) in VA cardiac catheterization laboratories. 
Cardiovascular revascularization medicine : including molecular interventions. 2014. 
25. Kinnaird TD, Ossei-Gerning N, Mitra R and Anderson RA. Interaction between 
access choice and pharmacotherapy for coronary intervention: the results of a UK survey. 
Open heart. 2014;1:e000094. 
26. Chhatriwalla AK, Amin AP, Kennedy KF, House JA, Cohen DJ, Rao SV, Messenger 
JC, Marso SP and National Cardiovascular Data R. Association between bleeding events and 
15 
 
in-hospital mortality after percutaneous coronary intervention. JAMA : the journal of the 
American Medical Association. 2013;309:1022-9. 
27. Verheugt FW, Steinhubl SR, Hamon M, Darius H, Steg PG, Valgimigli M, Marso SP, 
Rao SV, Gershlick AH, Lincoff AM, Mehran R and Stone GW. Incidence, prognostic impact, 
and influence of antithrombotic therapy on access and nonaccess site bleeding in 
percutaneous coronary intervention. JACC Cardiovascular interventions. 2011;4:191-7. 
28. Romagnoli E, Biondi-Zoccai G, Sciahbasi A, Politi L, Rigattieri S, Pendenza G, 
Summaria F, Patrizi R, Borghi A, Di Russo C, Moretti C, Agostoni P, Loschiavo P, Lioy E, 
Sheiban I and Sangiorgi G. Radial versus femoral randomized investigation in ST-segment 
elevation acute coronary syndrome: the RIFLE-STEACS (Radial Versus Femoral 
Randomized Investigation in ST-Elevation Acute Coronary Syndrome) study. Journal of the 
American College of Cardiology. 2012;60:2481-9. 
29. Bernat I, Horak D, Stasek J, Mates M, Pesek J, Ostadal P, Hrabos V, Dusek J, Koza J, 
Sembera Z, Brtko M, Aschermann O, Smid M, Polansky P, Al Mawiri A, Vojacek J, Bis J, 
Costerousse O, Bertrand OF and Rokyta R. ST-segment elevation myocardial infarction 
treated by radial or femoral approach in a multicenter randomized clinical trial: the STEMI-
RADIAL trial. Journal of the American College of Cardiology. 2014;63:964-72. 
30. Jolly SS, Yusuf S, Cairns J, Niemela K, Xavier D, Widimsky P, Budaj A, Niemela M, 
Valentin V, Lewis BS, Avezum A, Steg PG, Rao SV, Gao P, Afzal R, Joyner CD, 
Chrolavicius S, Mehta SR and group Rt. Radial versus femoral access for coronary 
angiography and intervention in patients with acute coronary syndromes (RIVAL): a 
randomised, parallel group, multicentre trial. Lancet. 2011;377:1409-20. 
31. Daugherty SL, Thompson LE, Kim S, Rao SV, Subherwal S, Tsai TT, Messenger JC 
and Masoudi FA. Patterns of use and comparative effectiveness of bleeding avoidance 
strategies in men and women following percutaneous coronary interventions: an 
observational study from the National Cardiovascular Data Registry. Journal of the American 
College of Cardiology. 2013;61:2070-8. 
32. Rafie IM, Uddin MM, Ossei-Gerning N, Anderson RA and Kinnaird TD. Patients 
undergoing PCI from the femoral route by default radial operators are at high risk of vascular 
access-site complications. EuroIntervention : journal of EuroPCR in collaboration with the 
Working Group on Interventional Cardiology of the European Society of Cardiology. 
2014;9:1189-94. 
33. Rubin DB. Multiple imputation after 18+ years. Journal of the American Statistical 
Association. 1996;91:473-489. 
34. Groenwold RH, Donders AR, Roes KC, Harrell FE, Jr. and Moons KG. Dealing with 
missing outcome data in randomized trials and observational studies. American journal of 
epidemiology. 2012;175:210-7. 
16 
 
Figure 1: Flowchart of patient inclusion/exclusion 
448853 patients operated 
between 2005 and 2012 in 
England and Wales*
423032 patients with 
femoral only or radial only 
access
25821 patients excluded (5.8%): 
unclear, missing or mixed 
operation access type
417038 patients (98.6% of 
patients with femoral only or 
radial only access)‡
179398 patients (42.4%) with at 
least one of these missing: age, 
sex, medical history variables, 
smoking information, indication 
for intervention, cardiogenic shock 
pre-op and ventilation pre-op† 
Multiple imputations that included 
all predictors possible for 173404 
(96.7%) of the patients with at 
least one missing predictor
 
 
* Population used in tables and graphs 
†Medical history variables included: diabetes, hypercholesterolaemia, hypertension, peripheral vascular disease, 
cerebrovascular event, renal history, previous MI, previous PCI, previous CABG and family history of CAD. 
‡ Subsample used in logistic regression analyses 
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Figure 2a: Change in radial access site adoption in Primary Care Trusts in England and Local 
Health Boards in Wales, 2005-2008 
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Figure 2b: Change in radial access site adoption in Primary Care Trusts in England and Local 
Health Boards in Wales, 2009-2012 
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Figure 3: Mean estimates of 30-day lives ‘saved’ (top) and ‘lost’ (bottom), by Strategic Health Authority over time*† 
 
 
* ‘Saved’, when compared to a hypothetical scenario where no radial access operations are performed in any areas 
† ‘Lost’, when compared to a hypothetical scenario where radial access rates across all strata are set to the highest percentage observed within each year 
